The exponential growth in molecular sequence data started in the early 1980s when methods for DNA sequencing became widely available. The data were accumulated in databases such as GenBank, EMBL ...

DelveInsight's DNA Diagnostics Market Insights report provides the current and forecast market analysis, individual leading ...

The use of microarrays to analyse gene expression on a global level has recently received a great deal of attention. There has been much speculation about the power of this approach in the analysis of ...

Asia-Pacific emerges as a key growth region. The global DNA diagnostics market is projected to grow from $13.2b in 2025 to ...

Background Gut microbial metabolites are recognised as critical effector molecules that influence the development of colorectal cancer (CRC). Peptidoglycan fragments (PGFs) produced by microbiota play ...

Introduction Fibroblastic foci represent the cardinal pathogenic lesion in idiopathic pulmonary fibrosis (IPF) and comprise activated fibroblasts and myofibroblasts, the key effector cells responsible ...

Next generation sequencing (NGS), massively parallel or deep sequencing are related terms that describe a DNA sequencing technology which has revolutionised genomic research. Using NGS an entire human ...

DelveInsight's Pharmacogenomic Testing Service Market Insights report provides the current and forecast market analysis, individual leading pharmacogenomic testing service companies' market shares, ...

The pharmacogenomic testing service market is witnessing strong growth, driven by the increasing adoption of personalized medicine and the growing recognition of genetic factors in drug response.

Dr. Lue Ping Zhao is a biostatistician with a background/experience in bioinformatics, epidemiology and genetics. He aims to accelerate the translation of big data technologies and findings to ...